Stryker Corporation plans to settle metal-on-metal hip replacement lawsuits against the company for more than $1.4 billion, according to the New York Times. The hip settlement would be the second highest of the last year, with thousands of patients receiving compensation for receiving what many alleged were defective devices that caused injuries.
Many patients who received a Stryker Rejuvenate or Stryker ABG II metal-on-metal hip replacement have complained of severe implant side effects, including premature loosening of the hip, tissue damage, limited mobility, and toxic levels of cobalt and chromium in the blood stream. These complications often require revision surgery to correct.
Stryker issued an ABG II and Rejuvenate recall in 2012 after studies found that the devices were more likely to fail than alternatives. The company joins several other metal-on-metal hip manufacturers who have begun settling metal hip injury lawsuits. Johnson & Johnson recently reached a hip lawsuit settlement for $2.5 billion.